Search filters

List of works by William A Fahy

A randomised, open-label study of umeclidinium versus glycopyrronium in patients with COPD

scientific article

A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 μg compared with tiotropium 18 μg in patients with COPD.

scientific article published on 7 April 2016

A randomized, parallel-group study to evaluate the efficacy of umeclidinium/vilanterol 62.5/25 μg on health-related quality of life in patients with COPD

scientific article published on 9 May 2016

AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPD.

scientific article

An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study.

scientific article published on 14 November 2017

Bronchoalveolar Lavage is Safe and Well Tolerated in Individuals with Idiopathic Pulmonary Fibrosis: An Analysis of the PROFILE Study

scientific article published on 28 August 2020

Dual Bronchodilator Therapy with Umeclidinium/Vilanterol Versus Tiotropium plus Indacaterol in Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial

scientific article published on 30 March 2016

Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study.

scientific article published on 20 October 2017

Pneumococcal and influenza vaccination in patients with rheumatic conditions and receiving DMARD therapy

scientific article published on 25 April 2006

Prevention of clinically important deteriorations in COPD with umeclidinium/vilanterol.

scientific article published on 24 June 2016

Relationship between exercise endurance and static hyperinflation in a post hoc analysis of two clinical trials in patients with COPD.

scientific article published on 8 January 2018

Safety, tolerability and pharmacokinetics of GSK3008348, a novel integrin αvβ6 inhibitor, in healthy participants.

scientific article published on 12 March 2018

The effect of umeclidinium added to inhaled corticosteroid/long-acting β2-agonist in patients with symptomatic COPD: a randomised, double-blind, parallel-group study

scientific article published on 23 June 2016

The topical study of inhaled drug (salbutamol) delivery in idiopathic pulmonary fibrosis

scientific article

Umeclidinium/vilanterol as step-up therapy from tiotropium in patients with moderate COPD: a randomized, parallel-group, 12-week study

scientific article published on 24 February 2017